Full-Time

Senior Manager

Growth Marketing, Paid Search

Confirmed live in the last 24 hours

Seed Health

Seed Health

201-500 employees

Develops and sells probiotic products online

Food & Agriculture
Education
Healthcare
Consumer Goods

Compensation Overview

$140k - $165kAnnually

+ Equity

Senior, Expert

Remote in USA

This position is 100% remote-US.

Category
Growth Marketing
Growth & Marketing
Required Skills
Data Analysis

You match the following Seed Health's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • 7+ years of Growth Marketing with experience in the health tech and/or CPG space, as well as successful, rapid-growth DTC businesses that are both brand and performance-focused and must comply with regulatory requirements
  • Proven track record of being able to develop and oversee a highly efficient, large scale ($30M+) Acquisition program that optimizes for LTV, ROI, or ROAS
  • Exceptional analytical skills that unlock performance-driving insights across channel, creative, and attribution disciplines
  • Strategic thinking who is also willing to dive into the weeds and be a scrappy problem solver
  • Highly effective communicator and collaborator, especially with Brand, and Integrated Marketing teams
  • Intuitive knowledge of the performance media landscape and how Seed's brand can best fit within it
  • Deep bias towards analytics and measurement, and extensive experience with having your work measured against or towards revenue-related goals
  • Comfort in serving as an externally facing representative of Seed and working closely with agency partners to advocate fiercely for Seed's interests
  • Comfort and ease working with finance teams to align on budgets, financial targets and the measurement of key financial performance metrics (i.e., CAC and LTV)
  • Ability to communicate complex information in an easily understood and thoughtful manner to cross-functional and external partners
  • No task too big or too small mindset - willing to roll up sleeves when needed to write ad copy, or to conduct performance analysis
Responsibilities
  • Execute a performance marketing strategy that aligns with the company's overall goals and objectives to drive growth for Seed’s flagship product, DS-01
  • Manage and optimize paid advertising campaigns across various channels (e.g., Paid Search and Paid Social) to drive efficient customer acquisition and revenue growth optimized to LTV/CAC ratio
  • Oversee the allocation of the performance marketing budget to ensure maximum ROI while meeting growth targets
  • Utilize data-driven insights to make informed marketing decisions, track and report on key performance metrics, and adjust strategies as needed to achieve performance goals
  • Implement A/B testing and experimentation across ad formats, audience targeting, landing pages to refine marketing strategies. Analyze test results to identify winning strategies and apply insights to improve overall channel performance
  • Support broader marketing analytics and attribution projects that help understand the impact of channels through incrementally testing, marginal ROI analysis and collaborating with data team on advanced attribution modeling
  • Stay informed about industry trends and competitor activities to identify growth opportunities and potential threats
  • Collaborate with influencer/ambassador program to expand our reach and drive performance marketing results
  • Serve at POC and Seed SME on execution of performance marketing channel strategy for DS-01

Seed Health focuses on developing and selling consumer products that utilize the benefits of microbes to enhance both human and planetary health. The company offers a range of scientifically-backed probiotics for humans and pets through its e-commerce platform, targeting health-conscious consumers interested in microbiome-related products. What sets Seed Health apart from its competitors is its strong emphasis on rigorous scientific research and innovation, ensuring that all products are effective and safe. Additionally, Seed Health engages in educational initiatives to promote awareness about microbial health, using creative marketing strategies to make scientific information accessible and engaging. The company's goal is to improve overall well-being by leveraging the power of microbes.

Company Size

201-500

Company Stage

Series A

Total Funding

$38.9M

Headquarters

Los Angeles, California

Founded

2016

Simplify Jobs

Simplify's Take

What believers are saying

  • Growing consumer interest in personalized health boosts demand for Seed Health's products.
  • Seed Health's environmental initiatives align with the trend towards sustainable products.
  • AI integration in microbiome research enhances the precision of Seed Health's offerings.

What critics are saying

  • Increased competition in vaginal health probiotics may impact Seed Health's market share.
  • Reliance on e-commerce exposes Seed Health to risks from digital platform changes.
  • Regulatory scrutiny on health claims could challenge Seed Health's marketing efforts.

What makes Seed Health unique

  • Seed Health collaborates with academic researchers for breakthrough microbial science discoveries.
  • The company offers clinically validated synbiotics like VS-01 for vaginal health.
  • Seed Health's CODA platform uses AI for precision microbiome interventions.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

401(k) Company Match

Mental Health Support

Wellness Program

Remote Work Options

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

3%

2 year growth

2%
The Chalkboard Mag
Aug 8th, 2024
I Tried Seed Health's New Vaginal Probiotic-Here's Why You Should Too

(In fact, one of its editors previously covered the Daily Synbiotic at The Chalkboard Mag) But it wasn't until Seed Health launched its VS-01(TM) Vaginal Synbiotic that I decided to give the brand a try to rebalance my microbiome and the rest of my system.

PR Newswire
Aug 1st, 2024
New Clinical Data Highlights Efficacy Of Seed Health'S Vs-01 Vaginal Synbiotic In Establishing Protective And Optimal Vaginal Microbiome

The study, which is the first to show that a multi-strain vaginal synbiotic can establish a protective vaginal environment, will be presented at the Annual Meeting of the Infectious Diseases Society for Obstetrics and Gynecology (IDSOG)The data demonstrate that VS-01™ successfully cultivates a vaginal microbiome dominated by Lactobacillus crispatus, reduces harmful microbes, and combats vaginal dysbiosisThese results underscore the potential of the vaginal microbiome and microbiome-directed innovations to redefine standards of care in women's healthBOSTON, Aug. 1, 2024 /PRNewswire/ -- Seed Health will present new clinical data on its flagship vaginal microbiome innovation, VS-01™ Vaginal Synbiotic, at the upcoming 2024 Infectious Diseases Society for Obstetrics and Gynecology (IDSOG) Annual Meeting. Data from a randomized, placebo-controlled clinical trial demonstrated the superior efficacy of VS-01™ in cultivating a stable and healthy vaginal microbiome. The synbiotic successfully established a protective environment dominated by Lactobacillus crispatus and inhibited harmful microbes associated with vaginal dysbiosis and inflammation. These findings highlight the transformative potential of proactive, preventive care centered on the vaginal microbiome, shifting the focus from traditional symptom management to maintaining a balanced and resilient vaginal ecology.A landmark 2012 study from vaginal microbiome researcher Jacques Ravel, Ph.D., demonstrated that the most stable and optimal vaginal microbiome is characterized by a dominance of the bacterium Lactobacillus crispatus, which plays a protective role in maintaining vaginal health. However, everyday factors such as menstruation, sexual activity, exercise, stress, contraceptives, and cleansers can deplete the abundance of L

Forbes
May 23rd, 2024
LA-Based Probiotic Company Hones In On Vaginal Health

LA-based probiotic company Seed is launching a new vaginal suppository that will help women maintain a more stable vaginal microbiome.

PR Newswire
May 21st, 2024
Seed Health Launches Vs-01, A First-Of-Its Kind Vaginal Microbiome Innovation To Redefine Vaginal Care

An optimal vaginal microbiome is a key driver of gynecological, urogenital, and reproductive healthVS-01™ is a multi-strain probiotic and prebiotic clinically validated to establish an optimal vaginal microbiome and sustain regulated vaginal pHBuilt on the research of renowned vaginal microbiome scientist Dr. Jacques Ravel, VS-01™ is the first to pioneer a microbial genomics approach powered by the most comprehensive host-microbiome vaginal data setLOS ANGELES, May 21, 2024 /PRNewswire/ -- Seed Health , a microbiome science company, today launched VS-01™ Vaginal Synbiotic, the first vaginal synbiotic clinically validated to rapidly establish an optimal vaginal microbiome dominated by Lactobacillus crispatus, the vagina's most protective bacteria. Dr. Jacques Ravel's pioneering research has elucidated the crucial role of the vaginal microbiome in gynecological, urogenital, and reproductive health, though everyday factors like stress, sex, menstruation, and diet can disrupt its equilibrium and deplete the abundance of L. crispatus. Dr

PR Newswire
May 20th, 2024
Seed Health To Present New Clinical Data On 'Ds-01® Daily Synbiotic' For Both Antibiotic Recovery And Ibs At Digestive Disease Week 2024

The company will present the results of two clinical trials that expand the potential health impact of its flagship 24-strain probiotic and prebiotic, DS-01®BOSTON, May 20, 2024 /PRNewswire/ -- Seed Health will present new clinical data on its flagship innovation, DS-01® Daily Synbiotic, a 24-strain probiotic and prebiotic, at the upcoming 2024 Digestive Disease Week® (DDW) meeting. The presentations will highlight the results from two randomized, double-blind, placebo-controlled clinical trials: one assessing the recovery effects of DS-01® on individuals during and following antibiotic usage, and another evaluating DS-01® in patients with irritable bowel syndrome (IBS). The findings underscore Seed's mission to transform breakthrough microbiome science into clinically validated consumer health innovations."DS-01® was formulated to maximize genomic diversity and set an entirely new standard in probiotics," stated Zain Kassam, M.D., M.P.H, Chief Medical Officer at Seed Health. "Our latest clinical data expands DS-01®'s potential health impact, broadens its clinical use cases, and helps dispel the common perception in the medical community that all probiotics are created equal."Dirk Gevers, Ph.D., Chief Scientific Officer at Seed Health, added, "The findings presented at DDW highlight the rigorous biopharma approach we bring to everyday health. We evaluated digestive well-being by studying biopharmaceutical-type biomarkers, exploring possible mechanisms of action in IBS, and conducting deeper microbiome sequencing than typical probiotic trials following antibiotics."DDW Presentation Highlights"Effects of a multi-species synbiotic on microbiome resilience and gastrointestinal barrier function after antibiotics: A randomized, double-blind, placebo-controlled clinical trial."This clinical trial evaluated the effects of DS-01® on individuals during and after antibiotic usage. Key findings include: DS-01® significantly improved short-term (25% at Day 7) and long-term (49% by Day 91) gut barrier integrity during and following broad-spectrum antibiotics